Clinical trials recruiting for Stage IV Pancreatic Cancer AJCC v8
19
Recruiting trials
51
US states with sites
2
Countries
0%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 8 |
| Florida | 7 |
| Illinois | 7 |
| Minnesota | 6 |
| Oregon | 6 |
| Missouri | 5 |
| Ohio | 5 |
| Pennsylvania | 5 |
| Wisconsin | 5 |
| Arizona | 4 |
| Arkansas | 4 |
| Colorado | 4 |
Top cities
Chicago, Illinois 6Portland, Oregon 6Atlanta, Georgia 4Cincinnati, Ohio 4Green Bay, Wisconsin 4Houston, Texas 4Lexington, Kentucky 4Sacramento, California 4St Louis, Missouri 4Wilmington, Delaware 4
Self-screener
Recruiting trials
- A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
- AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer
- BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma
- BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion
- CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
- Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer
- Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis
- Intravital Microscopy in Human Solid Tumors
- LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
- OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma
- Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma
- Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
- TR-002 for the Treatment of Advanced Unresectable Metastatic Solid Tumors Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma
- Targeted Pathway Inhibition in Patients With Pancreatic Cancer
- Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors
- Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
- Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
- Understanding New Cachexia Subtypes Through Observational Epidemiological Research
- iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
Related conditions
Trials recruiting for Stage IV Pancreatic Cancer AJCC v8 often also study these conditions. Each links to its own recruiting-trial list.
Pancreatic cancer 870Stage III Pancreatic Cancer AJCC v8 14Stage II Pancreatic Cancer AJCC v8 9Metastatic Pancreatic Carcinoma 8Metastatic Pancreatic Adenocarcinoma 10Unresectable Pancreatic Adenocarcinoma 4Stage IV Colorectal Cancer AJCC v8 21Colorectal cancer 1359Stage IV Lung Cancer AJCC v8 44Metastatic Pancreatic Ductal Adenocarcinoma 12
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Stage IV Pancreatic Cancer AJCC v8 trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.